Apollo Hospitals Enterprise Live BSE/NSE | Apollo Hospitals Enterprise Fundamenta data | Apollo Hospitals Enterprise Balance sheet | Apollo Hospitals Enterprise Quarterly Results | Apollo Hospitals Enterprise Profit & Loss | Apollo Hospitals Enterprise Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

28,869.86
152.31
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

31,998.66
0.29%
9.24

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.75
12.60
10.91

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.20
18.37
14.79

PAT CAGR (%)

10 Years
5 Years
3 Years

10.06
16.97
57.52

P:E (Median)

8 Years
5 Years
3 Years

56.21
68.91
83.28

P:BV (Average)

8 Years
5 Years
3 Years

5.28
5.44
5.53

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.98
22.93
21.30

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 1,962 2,229 -12% 2,572 2,167 19% 2,530 2,169 17% 2,464 2,090 18%
Expenses 1,920 1,903 1% 2,224 1,901 17% 2,153 1,901 13% 2,099 1,832 15%
EBITDA 41 326 -87% 348 266 31% 377 268 41% 364 258 41%
EBIDTM 2% 15% 0% 12% 15% 12% 15% 12%
Other Income 2 5 -64% -1 2 - 3 8 -63% 4 0 -
Interest 103 100 3% 107 71 51% 111 69 61% 108 66 63%
Depreciation 126 110 15% 129 77 68% 123 77 61% 120 74 63%
PBT -186 121 - 276 120 130% 146 130 12% 140 118 19%
Tax -37 42 - 70 43 62% 51 43 17% 50 39 28%
PAT -149 79 - 206 77 168% 95 87 9% 91 79 15%
PATM -8% 4% 3% 4% 4% 4% 4% 4%
EPS -10.73 5.71 - 14.79 5.52 168% 6.82 6.25 9% 6.52 5.68 15%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 2,172 2,572 -16% 2,922 2,500 17% 2,912 2,495 17% 2,841 2,412 18%
Expenses 2,136 2,208 -3% 2,542 2,220 15% 2,482 2,216 12% 2,427 2,140 13%
EBITDA 35 364 -90% 380 280 36% 430 279 54% 413 273 52%
EBIDTM 2% 14% 14% 11% 15% 11% 15% 11%
Other Income 8 10 -22% 4 12 -66% 10 12 -23% 4 3 37%
Interest 127 126 1% 135 85 58% 137 84 63% 134 81 66%
Depreciation 160 144 11% 164 105 56% 157 98 60% 155 97 59%
PBT -244 104 - 283 101 180% 145 109 33% 128 97 32%
Tax -41 45 - 74 39 89% 55 53 4% 51 42 21%
PAT -204 59 - 209 62 238% 90 56 61% 78 55 41%
PATM -9% 2% 7% 2% 3% 2% 3% 2%
EPS -14.65 4.21 - 15.05 4.45 238% 6.45 4.00 61% 5.58 3.97 41%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 9,527 9,794 8,337 7,183 6,301 5,588 4,593 3,862 3,318 2,800 2,332 Net Sales Growth 10% 17% 16% 14% 13% 22% 19% 16% 18% 20% Cost Of Goods Sold 4,293 5,182 4,369 3,801 3,364 2,865 2,424 2,002 1,720 1,455 1,228 Gross Profit 5,234 4,612 3,968 3,382 2,937 2,723 2,169 1,860 1,598 1,345 1,104 GP Margin 55% 47% 48% 47% 47% 49% 47% 48% 48% 48% 47% Total Expenditure 8,396 8,386 7,320 6,353 5,549 4,852 3,915 3,248 2,764 2,336 1,955 Power & Fuel Cost - 173 148 135 98 96 81 74 61 49 42 % Of Sales - 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% Employee Cost - 1,519 1,295 1,119 942 836 721 610 524 429 357 % Of Sales - 16% 16% 16% 15% 15% 16% 16% 16% 15% 15% Manufacturing Exp. - 414 336 344 318 270 210 174 138 122 98 % Of Sales - 4% 4% 5% 5% 5% 5% 4% 4% 4% 4% General & Admin Exp. - 984 1,057 867 755 721 434 359 297 255 211 % Of Sales - 10% 13% 12% 12% 13% 9% 9% 9% 9% 9% Selling & Distn. Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 113 115 87 72 64 44 28 25 26 0 % Of Sales - 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% EBITDA 1,131 1,409 1,017 830 752 737 678 614 554 464 377 EBITDA Margin 12% 14% 12% 12% 12% 13% 15% 16% 17% 17% 16% Other Income 8 17 14 13 48 40 45 22 31 28 18 Interest 429 426 268 240 200 134 83 87 73 64 55 Depreciation 499 482 300 272 241 200 158 129 109 91 71 PBT 376 518 462 330 359 443 482 420 403 338 269 Tax 134 212 160 97 74 83 121 89 99 107 88 Tax Rate 36% 31% 35% 29% 21% 20% 26% 21% 24% 32% 33% PAT 242 470 303 233 285 334 347 331 309 231 182 PAT before Minority Interest 242 470 303 233 285 334 347 331 309 231 182 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 3% 5% 4% 3% 5% 6% 8% 9% 9% 8% 8% PAT Growth -25% 55% 30% -18% -15% -4% 5% 7% 34% 27% EPS 17.40 33.83 21.78 16.78 20.51 24.03 24.94 23.79 22.24 16.62 13.07

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

9,527

9,794

8,337

7,183

6,301

5,588

4,593

3,862

3,318

2,800

2,332

Net Sales Growth

10%

17%

16%

14%

13%

22%

19%

16%

18%

20%

Cost Of Goods Sold

4,293

5,182

4,369

3,801

3,364

2,865

2,424

2,002

1,720

1,455

1,228

Gross Profit

5,234

4,612

3,968

3,382

2,937

2,723

2,169

1,860

1,598

1,345

1,104

GP Margin

55%

47%

48%

47%

49%

47%

48%

47%

Total Expenditure

8,396

8,386

7,320

6,353

5,549

4,852

3,915

3,248

2,764

2,336

1,955

Power & Fuel Cost

173

148

135

% Of Sales

Employee Cost

1,519

1,295

1,119

942

836

721

610

524

429

357

% Of Sales

16%

15%

16%

15%

Manufacturing Exp.

414

336

344

318

270

210

174

138

122

% Of Sales

General & Admin Exp.

984

1,057

867

755

721

434

359

297

255

211

% Of Sales

10%

13%

12%

13%

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

113

115

% Of Sales

EBITDA

1,131

1,409

1,017

830

752

737

678

614

554

464

377

EBITDA Margin

12%

14%

12%

13%

15%

16%

17%

16%

Other Income

Interest

429

426

268

240

200

134

Depreciation

499

482

300

272

241

200

158

129

109

PBT

376

518

462

330

359

443

482

420

403

338

269

Tax

134

212

160

121

107

Tax Rate

36%

31%

35%

29%

21%

20%

26%

21%

24%

32%

33%

PAT

242

470

303

233

285

334

347

331

309

231

182

PAT before Minority Interest

242

470

303

233

285

334

347

331

309

231

182

Minority Interest

PAT Margin

PAT Growth

-25%

55%

30%

-18%

-15%

-4%

34%

27%

EPS

17.40

33.83

21.78

16.78

20.51

24.03

24.94

23.79

22.24

16.62

13.07

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 10,846 11,247 9,617 8,243 7,256 6,215 5,178 4,384 3,769 3,148 2,605 Net Sales Growth 9% 17% 17% 14% 17% 20% 18% 16% 20% 21% Cost Of Goods Sold 8,652 5,499 4,661 4,033 3,599 3,055 2,581 2,150 1,856 1,562 1,315 Gross Profit 2,195 5,748 4,956 4,211 3,657 3,160 2,597 2,234 1,913 1,585 1,290 GP Margin 20% 51% 52% 51% 50% 51% 50% 51% 51% 50% 50% Total Expenditure 9,587 9,666 8,555 7,450 6,549 5,534 4,444 3,712 3,161 2,634 2,186 Power & Fuel Cost - 213 184 167 128 123 94 85 70 55 47 % Of Sales - 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% Employee Cost - 1,853 1,598 1,404 1,196 1,024 860 727 623 503 415 % Of Sales - 16% 17% 17% 16% 16% 17% 17% 17% 16% 16% Manufacturing Exp. - 519 420 453 430 393 247 200 158 137 112 % Of Sales - 5% 4% 6% 6% 6% 5% 5% 4% 4% 4% General & Admin Exp. - 1,445 1,551 1,272 1,101 863 612 516 423 350 278 % Of Sales - 13% 16% 15% 15% 14% 12% 12% 11% 11% 11% Selling & Distn. Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 138 141 121 95 78 50 33 31 27 0 % Of Sales - 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% EBITDA 1,259 1,581 1,063 793 707 680 735 672 608 513 419 EBITDA Margin 12% 14% 11% 10% 10% 11% 14% 15% 16% 16% 16% Other Income 25 33 32 32 44 53 37 21 30 26 15 Interest 534 533 327 295 257 180 118 119 103 89 78 Depreciation 636 620 396 359 314 264 212 168 142 124 95 PBT 312 462 373 171 180 289 442 407 393 326 261 Tax 139 225 173 112 91 97 130 102 105 115 87 Tax Rate 45% 34% 47% 65% 51% 32% 29% 25% 26% 35% 33% PAT 173 458 235 117 179 209 331 306 296 212 176 PAT before Minority Interest 196 435 199 59 89 208 325 305 294 211 174 Minority Interest 23 23 36 58 90 1 5 1 2 1 2 PAT Margin 2% 4% 2% 1% 2% 3% 6% 7% 8% 7% 7% PAT Growth -25% 95% 101% -34% -15% -37% 8% 4% 39% 21% EPS 12.43 32.95 16.91 8.43 12.85 15.05 23.78 22.04 21.27 15.27 12.63

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

10,846

11,247

9,617

8,243

7,256

6,215

5,178

4,384

3,769

3,148

2,605

Net Sales Growth

17%

14%

17%

20%

18%

16%

20%

21%

Cost Of Goods Sold

8,652

5,499

4,661

4,033

3,599

3,055

2,581

2,150

1,856

1,562

1,315

Gross Profit

2,195

5,748

4,956

4,211

3,657

3,160

2,597

2,234

1,913

1,585

1,290

GP Margin

20%

51%

52%

51%

50%

51%

50%

51%

50%

Total Expenditure

9,587

9,666

8,555

7,450

6,549

5,534

4,444

3,712

3,161

2,634

2,186

Power & Fuel Cost

213

184

167

128

123

% Of Sales

Employee Cost

1,853

1,598

1,404

1,196

1,024

860

727

623

503

415

% Of Sales

16%

17%

16%

17%

16%

Manufacturing Exp.

519

420

453

430

393

247

200

158

137

112

% Of Sales

General & Admin Exp.

1,445

1,551

1,272

1,101

863

612

516

423

350

278

% Of Sales

13%

16%

15%

14%

12%

11%

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

138

141

121

% Of Sales

EBITDA

1,259

1,581

1,063

793

707

680

735

672

608

513

419

EBITDA Margin

12%

14%

11%

10%

11%

14%

15%

16%

Other Income

Interest

534

533

327

295

257

180

118

119

103

Depreciation

636

620

396

359

314

264

212

168

142

124

PBT

312

462

373

171

180

289

442

407

393

326

261

Tax

139

225

173

112

130

102

105

115

Tax Rate

45%

34%

47%

65%

51%

32%

29%

25%

26%

35%

33%

PAT

173

458

235

117

179

209

331

306

296

212

176

PAT before Minority Interest

196

435

199

208

325

305

294

211

174

Minority Interest

PAT Margin

PAT Growth

-25%

95%

101%

-34%

-15%

-37%

39%

21%

EPS

12.43

32.95

16.91

8.43

12.85

15.05

23.78

22.04

21.27

15.27

12.63

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3,988 3,884 3,694 3,579 3,316 3,161 2,965 2,728 2,352 1,772 Share Capital 70 70 70 70 70 70 70 70 67 62 Total Reserves 3,919 3,814 3,624 3,509 3,246 3,092 2,895 2,658 2,246 1,641 Non-Current Liabilities 5,180 3,761 3,572 3,558 2,533 1,863 1,337 1,122 597 876 Secured Loans 2,500 2,529 2,402 2,475 1,857 1,306 839 861 369 484 Unsecured Loans 0 68 145 145 146 155 166 18 53 74 Long Term Provisions 968 849 769 694 0 0 0 0 0 205 Current Liabilities 1,943 1,633 1,315 750 989 796 555 505 544 507 Trade Payables 727 536 473 392 401 320 249 176 171 179 Other Current Liabilities 650 545 425 248 375 290 159 194 157 142 Short Term Borrowings 457 456 350 49 153 56 16 19 138 117 Short Term Provisions 108 96 68 62 59 130 132 115 77 68 Total Liabilities 11,112 9,278 8,581 7,888 6,838 5,820 4,857 4,354 3,493 3,155 Net Block 6,056 3,970 3,762 3,600 3,061 2,428 1,989 1,692 1,436 1,046 Gross Block 8,146 5,175 4,673 4,247 3,456 3,202 2,663 2,270 1,919 1,444 Accumulated Depreciation 2,090 1,205 912 647 395 774 674 579 483 399 Non Current Assets 8,797 7,275 6,601 6,143 5,128 4,124 3,499 2,912 2,529 2,366 Capital Work in Progress 227 819 698 328 536 512 481 373 201 352 Non Current Investment 1,049 1,073 898 978 795 599 542 525 647 516 Long Term Loans & Adv. 1,449 1,294 1,148 1,131 678 579 482 318 236 449 Other Non Current Assets 17 119 94 107 58 6 6 5 9 3 Current Assets 2,315 2,003 1,980 1,744 1,710 1,696 1,358 1,442 964 790 Current Investments 28 13 2 86 82 114 148 371 117 109 Inventories 707 561 539 442 381 332 265 205 183 151 Sundry Debtors 966 909 750 664 546 550 468 427 354 270 Cash & Bank 346 278 295 273 256 249 209 255 187 141 Other Current Assets 268 164 286 84 445 451 267 184 124 119 Short Term Loans & Adv. 90 78 108 196 372 420 249 169 98 101 Net Current Assets 372 370 665 994 721 900 803 937 420 282 Total Assets 11,112 9,278 8,581 7,888 6,838 5,820 4,857 4,354 3,493 3,155

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

3,988

3,884

3,694

3,579

3,316

3,161

2,965

2,728

2,352

1,772

Share Capital

Total Reserves

3,919

3,814

3,624

3,509

3,246

3,092

2,895

2,658

2,246

1,641

Non-Current Liabilities

5,180

3,761

3,572

3,558

2,533

1,863

1,337

1,122

597

876

Secured Loans

2,500

2,529

2,402

2,475

1,857

1,306

839

861

369

484

Unsecured Loans

145

146

155

166

Long Term Provisions

968

849

769

694

205

Current Liabilities

1,943

1,633

1,315

750

989

796

555

505

544

507

Trade Payables

727

536

473

392

401

320

249

176

171

179

Other Current Liabilities

650

545

425

248

375

290

159

194

157

142

Short Term Borrowings

457

456

350

153

138

117

Short Term Provisions

108

130

132

115

Total Liabilities

11,112

9,278

8,581

7,888

6,838

5,820

4,857

4,354

3,493

3,155

Net Block

6,056

3,970

3,762

3,600

3,061

2,428

1,989

1,692

1,436

1,046

Gross Block

8,146

5,175

4,673

4,247

3,456

3,202

2,663

2,270

1,919

1,444

Accumulated Depreciation

2,090

1,205

912

647

395

774

674

579

483

399

Non Current Assets

8,797

7,275

6,601

6,143

5,128

4,124

3,499

2,912

2,529

2,366

Capital Work in Progress

227

819

698

328

536

512

481

373

201

352

Non Current Investment

1,049

1,073

898

978

795

599

542

525

647

516

Long Term Loans & Adv.

1,449

1,294

1,148

1,131

678

579

482

318

236

449

Other Non Current Assets

119

107

Current Assets

2,315

2,003

1,980

1,744

1,710

1,696

1,358

1,442

964

790

Current Investments

114

148

371

117

109

Inventories

707

561

539

442

381

332

265

205

183

151

Sundry Debtors

966

909

750

664

546

550

468

427

354

270

Cash & Bank

346

278

295

273

256

249

209

255

187

141

Other Current Assets

268

164

286

445

451

267

184

124

119

Short Term Loans & Adv.

108

196

372

420

249

169

101

Net Current Assets

372

370

665

994

721

900

803

937

420

282

Total Assets

11,112

9,278

8,581

7,888

6,838

5,820

4,857

4,354

3,493

3,155

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3,339 3,334 3,252 3,313 3,331 3,171 2,977 2,747 2,507 1,899 Share Capital 70 70 70 73 70 70 70 70 67 62 Total Reserves 3,266 3,261 3,180 3,239 3,261 3,101 2,907 2,677 2,401 1,768 Non-Current Liabilities 6,483 4,613 4,423 4,399 2,701 2,138 1,557 1,316 737 1,046 Secured Loans 2,852 2,869 2,728 2,478 2,303 1,563 1,050 1,057 514 650 Unsecured Loans 0 83 195 476 147 165 172 21 60 98 Long Term Provisions 1,011 883 785 701 3 3 2 3 2 208 Current Liabilities 2,337 1,955 1,567 963 1,250 1,076 797 734 726 633 Trade Payables 909 713 606 501 550 419 280 222 190 192 Other Current Liabilities 808 641 502 296 446 440 321 337 283 228 Short Term Borrowings 498 498 379 71 183 86 62 58 175 143 Short Term Provisions 123 103 80 96 71 132 133 117 78 69 Total Liabilities 12,290 10,037 9,374 8,800 7,360 6,459 5,350 4,814 3,983 3,602 Net Block 7,426 4,975 4,766 4,583 3,997 3,244 2,681 2,341 2,011 1,530 Gross Block 10,222 6,600 6,024 5,499 4,609 4,285 3,571 3,097 2,641 2,048 Accumulated Depreciation 2,796 1,624 1,258 916 612 1,041 889 756 626 514 Non Current Assets 9,643 7,756 7,154 6,671 5,385 4,520 3,849 3,261 2,920 2,724 Capital Work in Progress 236 822 712 347 562 533 491 403 209 361 Non Current Investment 365 399 301 308 271 165 166 148 442 386 Long Term Loans & Adv. 1,598 1,432 1,255 1,326 498 578 510 369 249 444 Other Non Current Assets 18 128 120 107 57 0 0 0 9 3 Current Assets 2,647 2,282 2,220 2,129 1,975 1,939 1,501 1,553 1,062 879 Current Investments 75 69 58 106 82 146 156 379 122 116 Inventories 738 585 566 467 406 350 279 219 192 158 Sundry Debtors 1,027 1,023 825 751 609 609 520 473 387 300 Cash & Bank 467 347 417 524 379 377 274 320 237 178 Other Current Assets 340 179 242 58 499 456 273 163 125 126 Short Term Loans & Adv. 97 79 112 223 437 420 241 139 98 99 Net Current Assets 310 326 653 1,166 725 863 704 819 336 246 Total Assets 12,290 10,037 9,374 8,800 7,360 6,459 5,350 4,814 3,983 3,602

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

3,339

3,334

3,252

3,313

3,331

3,171

2,977

2,747

2,507

1,899

Share Capital

Total Reserves

3,266

3,261

3,180

3,239

3,261

3,101

2,907

2,677

2,401

1,768

Non-Current Liabilities

6,483

4,613

4,423

4,399

2,701

2,138

1,557

1,316

737

1,046

Secured Loans

2,852

2,869

2,728

2,478

2,303

1,563

1,050

1,057

514

650

Unsecured Loans

195

476

147

165

172

Long Term Provisions

1,011

883

785

701

208

Current Liabilities

2,337

1,955

1,567

963

1,250

1,076

797

734

726

633

Trade Payables

909

713

606

501

550

419

280

222

190

192

Other Current Liabilities

808

641

502

296

446

440

321

337

283

228

Short Term Borrowings

498

379

183

175

143

Short Term Provisions

123

103

132

133

117

Total Liabilities

12,290

10,037

9,374

8,800

7,360

6,459

5,350

4,814

3,983

3,602

Net Block

7,426

4,975

4,766

4,583

3,997

3,244

2,681

2,341

2,011

1,530

Gross Block

10,222

6,600

6,024

5,499

4,609

4,285

3,571

3,097

2,641

2,048

Accumulated Depreciation

2,796

1,624

1,258

916

612

1,041

889

756

626

514

Non Current Assets

9,643

7,756

7,154

6,671

5,385

4,520

3,849

3,261

2,920

2,724

Capital Work in Progress

236

822

712

347

562

533

491

403

209

361

Non Current Investment

365

399

301

308

271

165

166

148

442

386

Long Term Loans & Adv.

1,598

1,432

1,255

1,326

498

578

510

369

249

444

Other Non Current Assets

128

120

107

Current Assets

2,647

2,282

2,220

2,129

1,975

1,939

1,501

1,553

1,062

879

Current Investments

106

146

156

379

122

116

Inventories

738

585

566

467

406

350

279

219

192

158

Sundry Debtors

1,027

1,023

825

751

609

520

473

387

300

Cash & Bank

467

347

417

524

379

377

274

320

237

178

Other Current Assets

340

179

242

499

456

273

163

125

126

Short Term Loans & Adv.

112

223

437

420

241

139

Net Current Assets

310

326

653

1,166

725

863

704

819

336

246

Total Assets

12,290

10,037

9,374

8,800

7,360

6,459

5,350

4,814

3,983

3,602

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 1,096 907 539 632 626 389 303 333 306 195 PBT 470 303 233 285 417 467 420 408 338 269 Adjustment 1,008 775 652 512 339 240 213 159 145 118 Changes in Working Capital -131 -14 -228 -71 6 -223 -225 -145 -114 -127 Cash after chg. in Working capital 1,347 1,064 657 727 762 484 408 422 368 260 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -251 -157 -118 -95 -133 -94 -106 -89 -62 -66 Other Direct Exp. Paid 0 0 0 0 -3 -1 1 0 0 1 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -264 -776 -378 -804 -910 -681 -310 -631 -446 -398 Net Fixed Assets -2,379 -622 -797 -583 -278 -570 -501 -523 -323 -268 Net Investments 9 -185 163 -187 -164 -23 206 -132 -140 -134 Others 2,106 32 255 -34 -467 -88 -14 24 17 4 Cash from Financing Activity -771 -160 -106 130 290 332 -40 367 185 59 Net Cash Inflow / Outflow 62 -28 54 -42 7 40 -47 69 46 -144 Opening Cash & Equivalents 219 247 192 235 249 209 255 187 141 286 Closing Cash & Equivalent 280 219 247 192 256 249 209 255 187 141

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

1,096

907

539

632

626

389

303

333

306

195

PBT

470

303

233

285

417

467

420

408

338

269

Adjustment

1,008

775

652

512

339

240

213

159

145

118

Changes in Working Capital

-131

-14

-228

-71

-223

-225

-145

-114

-127

Cash after chg. in Working capital

1,347

1,064

657

727

762

484

408

422

368

260

Interest Paid

Tax Paid

-251

-157

-118

-95

-133

-94

-106

-89

-62

-66

Other Direct Exp. Paid

-3

-1

Extra & Other Items

Cash From Investing Activity

-264

-776

-378

-804

-910

-681

-310

-631

-446

-398

Net Fixed Assets

-2,379

-622

-797

-583

-278

-570

-501

-523

-323

-268

Net Investments

-185

163

-187

-164

-23

206

-132

-140

-134

Others

2,106

255

-34

-467

-88

-14

Cash from Financing Activity

-771

-160

-106

130

290

332

-40

367

185

Net Cash Inflow / Outflow

-28

-42

-47

-144

Opening Cash & Equivalents

219

247

192

235

249

209

255

187

141

286

Closing Cash & Equivalent

280

219

247

192

256

249

209

255

187

141

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 1,293 905 537 623 597 470 373 443 387 259 PBT 657 374 60 131 305 455 407 399 326 261 Adjustment 1,012 770 808 704 425 275 290 227 210 169 Changes in Working Capital -70 -46 -205 -78 11 -161 -214 -90 -87 -104 Cash after chg. in Working capital 1,599 1,098 662 756 741 569 483 536 449 326 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -306 -192 -125 -134 -141 -100 -110 -93 -63 -68 Other Direct Exp. Paid 0 0 0 0 -3 1 1 0 1 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -289 -711 -405 -1,152 -888 -759 -356 -733 -468 -441 Net Fixed Assets -2,379 -622 -797 -583 -278 -570 -501 -523 -323 -268 Net Investments 9 -185 163 -187 -164 -23 206 -132 -140 -134 Others 2,081 97 228 -383 -446 -166 -61 -78 -5 -39 Cash from Financing Activity -910 -215 -108 477 330 392 -63 373 135 47 Net Cash Inflow / Outflow 94 -20 24 -52 39 103 -46 83 54 -136 Opening Cash & Equivalents 286 306 283 335 340 274 320 237 182 314 Closing Cash & Equivalent 381 286 306 283 379 377 274 320 237 178

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

1,293

905

537

623

597

470

373

443

387

259

PBT

657

374

131

305

455

407

399

326

261

Adjustment

1,012

770

808

704

425

275

290

227

210

169

Changes in Working Capital

-70

-46

-205

-78

-161

-214

-90

-87

-104

Cash after chg. in Working capital

1,599

1,098

662

756

741

569

483

536

449

326

Interest Paid

Tax Paid

-306

-192

-125

-134

-141

-100

-110

-93

-63

-68

Other Direct Exp. Paid

-3

Extra & Other Items

Cash From Investing Activity

-289

-711

-405

-1,152

-888

-759

-356

-733

-468

-441

Net Fixed Assets

-2,379

-622

-797

-583

-278

-570

-501

-523

-323

-268

Net Investments

-185

163

-187

-164

-23

206

-132

-140

-134

Others

2,081

228

-383

-446

-166

-61

-78

-5

-39

Cash from Financing Activity

-910

-215

-108

477

330

392

-63

373

135

Net Cash Inflow / Outflow

-20

-52

103

-46

-136

Opening Cash & Equivalents

286

306

283

335

340

274

320

237

182

314

Closing Cash & Equivalent

381

286

306

283

379

377

274

320

237

178

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 287 279 265 257 238 227 213 196 172 137 ROA 5% 3% 3% 4% 5% 6% 7% 8% 7% 6% ROE 12% 8% 6% 8% 10% 11% 12% 12% 12% 11% ROCE 16% 11% 9% 9% 10% 12% 13% 14% 15% 14% Fixed Asset Turnover 1.47 1.69 1.61 1.64 1.68 1.57 1.57 1.58 1.67 1.73 Receivable days 35 36 36 35 36 40 42 43 41 37 Inventory Days 24 24 25 24 23 24 22 21 22 22 Payable days 30 29 28 29 31 29 26 25 30 36 Cash Conversion Cycle 29 32 33 30 28 35 39 39 33 23 Total Debt/Equity 0.79 0.83 0.81 0.77 0.71 0.53 0.36 0.35 0.27 0.43 Interest Cover 3 3 2 3 4 7 6 7 6 6

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

287

279

265

257

238

227

213

196

172

137

ROA

ROE

12%

10%

11%

12%

11%

ROCE

16%

11%

10%

12%

13%

14%

15%

14%

Fixed Asset Turnover

1.47

1.69

1.61

1.64

1.68

1.57

1.58

1.67

1.73

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.79

0.83

0.81

0.77

0.71

0.53

0.36

0.35

0.27

0.43

Interest Cover

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 239 239 233 237 239 228 214 197 184 147 ROA 4% 2% 1% 1% 3% 6% 6% 7% 6% 5% ROE 13% 6% 2% 3% 6% 11% 11% 11% 10% 10% ROCE 17% 10% 7% 7% 9% 12% 13% 14% 13% 13% Fixed Asset Turnover 1.34 1.52 1.43 1.44 1.40 1.32 1.32 1.31 1.34 1.37 Receivable days 33 35 35 34 36 40 41 42 40 37 Inventory Days 21 22 23 22 22 22 21 20 20 21 Payable days 34 33 31 34 36 32 27 26 29 36 Cash Conversion Cycle 21 24 26 22 22 30 35 35 31 22 Total Debt/Equity 1.08 1.10 1.06 0.95 0.85 0.63 0.45 0.44 0.33 0.52 Interest Cover 2 2 2 2 3 5 4 5 5 4

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

239

233

237

239

228

214

197

184

147

ROA

ROE

13%

11%

10%

ROCE

17%

10%

12%

13%

14%

13%

Fixed Asset Turnover

1.34

1.52

1.43

1.44

1.40

1.32

1.31

1.34

1.37

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

1.08

1.10

1.06

0.95

0.85

0.63

0.45

0.44

0.33

0.52

Interest Cover

Apollo Hospitals Enterprise Ltd.

Hospital & Healthcare Services

BSE: 508869 | NSE: APOLLOHOSP

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

Apollo Hospitals Enterprise Ltd.

Hospital & Healthcare Services

BSE: 508869 | NSE: APOLLOHOSP

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update